Citalopramin preventing depression in moderate TBI
Phase 3
- Conditions
- Moderate brain trauma.S06.2Diffuse tr
- Registration Number
- IRCT20221108056446N9
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Patients with a consciousness coefficient between 9 and 13
Conscious consent of first -degree companions to enter the study
Complete recovery from trauma 4 weeks after the incident
Patients with a history of mood disorder must be in complete remission for at least 1 year after discontinuation of treatment
Exclusion Criteria
Patients with persistent depression or any other mood disorder based on medical records and doctor's definitive diagnosis
Pregnant women or women who plan to become pregnant during the study period
Previous history of allergy to Citalopramin
Complex and debilitating underlying disease such as cancer, advanced heart failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method